To exclude the possibility that TLR3 activation is breast cancer cell-type specific, we also examined the breast ductal carcinoma cell line BT-483, adenocarcinoma cell line Cama-1 and triple-negative inflammatory breast cancer cell line SUM149. This evidence concerns the gene TLR3 and breast carcinoma.